Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 36.64%28.55M | -63.22%16.89M | 28.15%47.67M | 6.47%145.45M | 0.98%41.43M | -78.14%20.89M | 45.92M | 37.2M | 136.61M | 41.03M |
| Operating revenue | 36.64%28.55M | -63.22%16.89M | 28.15%47.67M | 6.47%145.45M | 0.98%41.43M | -78.14%20.89M | --45.92M | --37.2M | --136.61M | --41.03M |
| Cost of revenue | 2.91%30.08M | -20.83%23.56M | 19.47%34.22M | 64.65%114.6M | -22.87%26.96M | -15.63%29.23M | 29.77M | 28.64M | 69.6M | 34.96M |
| Gross profit | 81.61%-1.53M | -141.32%-6.68M | 57.18%13.46M | -53.96%30.85M | 138.21%14.47M | -113.68%-8.34M | 16.16M | 8.56M | 67.01M | 6.08M |
| Operating expense | 2.95%7.53M | -46.34%5.68M | -24.73%6.72M | -54.82%38.48M | -24.03%11.73M | -38.34%7.32M | -69.16%10.59M | -64.51%8.93M | -10.60%85.18M | -74.60%15.44M |
| Selling and administrative expenses | -26.35%5.17M | -28.05%4.96M | -23.02%5.74M | -63.76%28.43M | -48.57%7.01M | -31.18%7.01M | -79.47%6.9M | -66.40%7.46M | -16.14%78.45M | -76.92%13.63M |
| -Selling and marketing expense | -51.79%189K | -38.74%359K | -64.54%378K | 6.94%4.79M | 482.24%3.16M | -70.77%392K | --586K | --1.07M | 142.65%4.48M | -70.60%542.48K |
| -General and administrative expense | -24.85%4.98M | -27.06%4.6M | -16.10%5.36M | -68.04%23.64M | -70.58%3.85M | -25.18%6.62M | -81.22%6.31M | -71.21%6.39M | -19.33%73.98M | -77.13%13.08M |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | ---- | -68.91%209.53K | -50.09%276K | ---- | ---- |
| Depreciation amortization depletion | --9K | 31.82%29K | -4.35%22K | -42.23%76.64K | 75.58%76.64K | --0 | -28.89%22K | -8.50%23K | 76.53%132.67K | --43.65K |
| -Depreciation and amortization | --9K | 31.82%29K | -4.35%22K | -42.23%76.64K | 75.58%76.64K | --0 | -28.89%22K | -8.50%23K | 76.53%132.67K | --43.65K |
| Other taxes | --1.36M | -99.19%8K | -33.33%6K | 42.79%4.69M | 141.60%3.71M | --0 | 41.69%989K | -99.08%9K | 272.47%3.29M | --1.53M |
| Other operating expenses | 228.62%999K | -74.51%684K | -33.87%953K | 59.61%5.28M | 304.86%935.92K | -71.26%304K | 16,831.14%2.68M | -26.59%1.44M | 328.65%3.31M | --231.17K |
| Operating profit | 42.09%-9.07M | -322.03%-12.36M | 1,914.82%6.73M | 57.99%-7.63M | 129.33%2.74M | -131.90%-15.66M | 116.21%5.57M | 98.53%-371K | 80.93%-18.17M | 84.60%-9.36M |
| Net non-operating interest income (expenses) | 6.19%-5.94M | -22.08%-4.52M | -11.24%-4.29M | -97.29%-23.37M | -118.90%-9.4M | -60.32%-6.33M | 1.63%-3.7M | -668.95%-3.85M | -13,608.78%-11.84M | -3,940.74%-4.29M |
| Non-operating interest income | 71.34%629K | -64.80%685K | -21.48%925K | 53.62%3.89M | 866.65%1.18M | 91.19%367.11K | 235.35%1.95M | -21.78%1.18M | 642.44%2.53M | -145.11%-153.89K |
| Non-operating interest expense | -0.37%6.14M | -5.90%5.11M | 5.09%5.14M | 56.67%21.7M | -0.77%5.56M | 62.78%6.16M | 45.29%5.43M | 1,266.29%4.89M | 5,365.38%13.85M | 2,343.44%5.6M |
| Total other finance cost | 152.05%431K | -55.16%100K | -48.59%73K | 959.14%5.56M | 443.08%5.02M | -52.07%171K | -63.47%223K | -69.85%142K | --524.65K | ---1.46M |
| Other net income (expenses) | 258.38%3.33M | 86.71%-1.98M | 330.70%7.28M | -611.33%-31.96M | -448.25%-11.82M | 46.11%-2.1M | -431.82%-14.89M | -230.23%-3.16M | 326.94%6.25M | 185.36%3.39M |
| Gain on sale of security | 258.38%3.33M | 139.49%5.88M | 330.70%7.28M | -605.04%-31.57M | -436.67%-11.42M | 46.11%-2.1M | -431.82%-14.89M | -230.23%-3.16M | 326.94%6.25M | 207.57%3.39M |
| Special income (charges) | --0 | ---7.86M | ---- | ---392.98K | ---392.98K | --0 | ---- | ---- | --0 | --0 |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --392.98K | --76.2K | --316.78K | ---- | ---- | --0 | --0 |
| -Less:Write off | --0 | --7.86M | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | 51.51%-11.68M | -44.78%-18.86M | 231.82%9.73M | -164.93%-62.96M | -80.02%-18.47M | -158.43%-24.09M | 61.25%-13.03M | 66.56%-7.38M | 74.64%-23.77M | 82.75%-10.26M |
| Income tax | -110.17%-103K | 0 | 1,161.57%5M | -380.40%-14.2M | -6,360.56%-12.57M | -80.74%1.01M | -2.18M | -471K | 5.06M | -194.5K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 53.88%-11.58M | -73.85%-18.86M | 168.43%4.73M | -69.13%-48.76M | 41.32%-5.91M | -169.79%-25.1M | 67.73%-10.85M | 68.69%-6.91M | 69.24%-28.83M | 83.07%-10.07M |
| Net income continuous operations | 53.88%-11.58M | -73.85%-18.86M | 168.43%4.73M | -69.13%-48.76M | 41.32%-5.91M | -169.79%-25.1M | 67.73%-10.85M | 68.69%-6.91M | 69.24%-28.83M | 83.07%-10.07M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 53.88%-11.58M | -73.85%-18.86M | 168.43%4.73M | -69.13%-48.76M | 41.32%-5.91M | -169.79%-25.1M | 67.73%-10.85M | 68.69%-6.91M | 69.24%-28.83M | 83.07%-10.07M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 53.88%-11.58M | -73.85%-18.86M | 168.43%4.73M | -69.13%-48.76M | 41.32%-5.91M | -169.79%-25.1M | 67.73%-10.85M | 68.69%-6.91M | 69.24%-28.83M | 83.07%-10.07M |
| Diluted earnings per share | 56.52%-0.1 | -70.00%-0.17 | 167.98%0.0425 | -66.38%-0.439 | 12.81%-0.0697 | -165.13%-0.23 | 69.18%-0.1 | 70.85%-0.0625 | 71.58%-0.2638 | 86.33%-0.0799 |
| Basic earnings per share | 56.52%-0.1 | -70.00%-0.17 | 167.98%0.0425 | -66.38%-0.439 | 8.36%-0.0732 | -165.13%-0.23 | 69.18%-0.1 | 70.85%-0.0625 | 71.58%-0.2638 | 86.33%-0.0799 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.